Revvity

Yahoo Finance • 10 days ago

Here’s Artisan Mid Cap Value Fund’s Investment Thesis for Revvity (RVTY)

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Value Fund”.  A copy of the letter can be downloaded here. The Fund seeks to invest in undervalued companies with sol... Full story

Yahoo Finance • 26 days ago

Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4

Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to download here. In 2025, the strategy retu... Full story

Yahoo Finance • last month

2 Cash-Producing Stocks for Long-Term Investors and 1 We Find Risky

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Not all companies are... Full story

Yahoo Finance • 2 months ago

Stock Indexes Climb as Chip Makers and AI Infrastructure Stocks Rebound

The S&P 500 Index ($SPX) (SPY) today is up +0.25%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.57%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.42%.  March E-mini S&P futures (ESH26) are up +0.20%, and March E-mini Nasdaq fu... Full story

Yahoo Finance • 2 months ago

Revvity Q4 Earnings Call Highlights

Revvity logo Revvity (NYSE:RVTY) executives said the company ended 2025 with results that exceeded internal expectations, helped by better-than-anticipated performance in diagnostics and improving trends in parts of the life sciences port... Full story

Yahoo Finance • 2 months ago

Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter

Feb 2 (Reuters) - Medical equipment maker Revvity handily beat fourth-quarter estimates and forecast 2026 revenue and profit ​above Wall Street expectations on Monday, betting on ‌continued strength in its diagnostics business even as weak... Full story

Yahoo Finance • 4 months ago

Revvity to Present at J.P. Morgan Healthcare Conference

WALTHAM, Mass., December 18, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) will present at the 44th annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 9:45 a.m. PT. President and Chief Executive Officer Prahlad S... Full story

Yahoo Finance • 4 months ago

Notable healthcare headlines for the week: Sanofi, Eli Lilly, and Novo Nordisk in focus

U.S. stocks rallied over the trading week, shortened by the Thanksgiving holiday and a reduced trading session on Friday. The S&P 500 was up around 4% during the week, while the Dow rose a similar amount and the tech-focused Nasdaq Compos... Full story

Yahoo Finance • 5 months ago

Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus

Wall Street staged a rebound on Friday, closing the session in positive territory after a turbulent, tech-driven downturn rattled the Nasdaq Composite just a day earlier. Friday's market boost was supported by reports that the Trump admin... Full story

Yahoo Finance • 5 months ago

Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more

Here's a list of key deals reported across sectors this week: Merck (MRK [https://seekingalpha.com/symbol/MRK]) to acquire [https://seekingalpha.com/pr/20307875-merck-to-acquire-cidara-therapeutics-inc-diversifying-its-portfolio-to-includ... Full story

Yahoo Finance • 5 months ago

Revvity Non-GAAP EPS of $1.18 beats by $0.04, revenue of $699M in-line

* Revvity press release [https://seekingalpha.com/pr/20279750-revvity-announces-financial-results-for-the-third-quarter-of-2025] (NYSE:RVTY [https://seekingalpha.com/symbol/RVTY]): Q3 Non-GAAP EPS of $1.18 beats by $0.04. * Revenue of... Full story

Yahoo Finance • 5 months ago

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Alliance Resource Partners, L.P. (ARLP [https://seekingalpha.com/symbol/ARLP]) * Daqo New Energy Corp. (DQ [https://seekingalpha.com/symbol/DQ]) * Easterly Government Prop... Full story

Yahoo Finance • 6 months ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk and J&J in focus

U.S. stocks wavered amid increased volatility on Friday but managed to resurge, as Wall Street was rattled by concerns on the health of regional banks and credit risks while the U.S. government shutdown entered its 17th day. The benchmark... Full story

Yahoo Finance • 6 months ago

Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]), which tracks the... Full story

Yahoo Finance • 6 months ago

Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The S&P 500 Healthcare sector (XLV) saw a slight increase in average short interest in September, rising to 1.91% fr... Full story

Yahoo Finance • 6 months ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening WALTHAM, Mass., October 02, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced a program... Full story

Yahoo Finance • 6 months ago

Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

New software further strengthens Revvity’s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights WALTHAM, Mass., September 29, 2025--(BUSINESS WIRE)--Today Revvity, Inc. (NYSE: RVTY... Full story

Yahoo Finance • 7 months ago

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development of novel gene editing therapies WALTHAM, Mass., September 22, 2025--(BUSINESS WIRE)--Revvity, Inc. (... Full story

Yahoo Finance • 7 months ago

Notable healthcare headlines for the week: Novo Nordisk, Hims & Hers and UnitedHealth in focus

Wall Street finished the week on a strong note as all three major market averages tagged record levels on Friday. For the week, the Nasdaq (COMP:IND), S&P 500 (SP500), and Dow (DJI) rose by 2.21%, 1.22%, and 1.05%, respectively. The S&P... Full story

Yahoo Finance • 7 months ago

Notable healthcare headlines for the week: Novartis, Cigna and Sanofi in focus

Wall Street’s broader market averages finished Friday lower after taking back earlier gains on Friday. At the end of trading the blue-chip Dow(DJI [https://seekingalpha.com/symbol/DJI]) handed back 0.48% while the benchmark S&P 500 (SP500... Full story